How Our Helpline Works

For those seeking addiction treatment for themselves or a loved one, the helpline is a private and convenient solution.

Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by American Addiction Centers (AAC).

We are standing by 24/7 to discuss your treatment options. Our representatives work solely for AAC and will discuss whether an AAC facility may be an option for you.

Our helpline is offered at no cost to you and with no obligation to enter into treatment. Neither nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.

For more information on AAC’s commitment to ethical marketing and treatment practices, or to learn more about how to select a treatment provider, visit our About AAC page.

If you wish to explore additional treatment options or connect with a specific rehab center, you can browse top-rated listings, or visit SAMHSA.

Ready for help?

Our team is on hand

Who Answers?

Over the Counter Naloxine: Enabler or Prevention Tactic?

by | Addiction, Alcohol and Drugs, Latest News, Recovery, Research

Home Addiction Over the Counter Naloxine: Enabler or Prevention Tactic?

In the event of an opiate overdose Naloxine, not to be confused with Naltrexone, is an emergency overdose resuscitation drug. Opiates such as heroin and oxycodone are taking lives across the nation as well as the world. If an overdose patient is brought to the hospital, if available, they can revive the patient by inducing Naloxine. Currently the drug is used in emergency rooms. Maia Szalavitz of Time entices the idea of readily making Naloxine available to the public, stating that the studies have shown great success of intervening overdose by means of Naloxine. In 17 states already they have begun researching and implementing pilot studies on the necessity and success of distributing Naloxine. Specifically Boston, Massachusetts has projected this success. The death by overdose rate has declined greatly in Boston since introducing Naloxine to opiate abusers.
Concerns of making Naloxine available to the public is that it will concurrently be used as an enabler to continue abusing opiates. Without the education of drug addiction and how the disease works, Naloxine could be misled as the solution to their problem versus recovery. The fact is that Naloxine is saving lives, but education on recovery and treatment should be a primary objective as well. Obviously suffering addicts primarily like instant gratification versus a process that may thread their entire lives. If Naloxine is considered for availability perhaps there could be some kind of integration of addiction education. The only people that are going to be running into a pharmacy for an overdose intervention drug are desperate companions of someone who is dying from addiction. This is a situation where there must be some notion that recovery is necessary.